Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma

Surasak Phuphanich, Kathryn A. Carson, Stuart A. Grossman, Glenn Lesser, Jeffrey Olson, Tom Mikkelsen, Serena Desideri, Joy D. Fisher

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma'. Together they form a unique fingerprint.

Medicine & Life Sciences